Results from an early safety study of Moderna's coronavirus vaccine candidate in older adults showed that it produced virus-neutralizing antibodies at levels similar to those seen in younger adults, with side effects roughly on par with high-dose flu shots.
Subscribe to:
Post Comments (Atom)
Comments
Post a Comment
Leave a comment. Thanks!
Comentarios de Facebook